Roche, Gilead regulatory submission

Roche (SWX:ROCZ) submitted Tamiflu oseltamivir oral neuraminidase inhibitor to the EMEA's Committee for Proprietary Medicinal Products (CPMP) for the treatment of influenza A and B in adults and child...